Visit the FDA MedWatch website or call 1-800-FDA-1088
Tirzepatide and semaglutide are two regularly used type 2 diabetes weight-management medications
A personalized approach ensures you get comprehensive benefits
Specifically, high attained dose was associated with lower: all-cause mortality (RR = 0.42, P 25% group, with a mean patient-level change of 0.2% versus 0.8% relative to the pre-treatment baseline measurement ( P 25% weight loss group (126 mmHg versus 13 mmHg, P 25% weight loss group (75.4 mmHg versus 78.0 mmHg) and progressively larger patient-level declines relative to baseline across the different weight loss strata ( P = 0.002
However, compounded tirzepatide generally costs significantly less than brand-name Mounjaro, which lists at approximately $1,000 to $1,200 per month without insurance coverage
In response, compounding pharmacies began creating alternative formulations for patients who couldnt access or afford the name-brand versions